Halozyme Therapeutics, Inc. (HALO) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 1B | 825.21M | 1.33B | 1.12B | 1.26B | 1.09B | 1.13B | 987.8M | 873.58M | 746.42M | 879.01M | 765.75M | 615.02M | 739.01M | 653.2M | 541.94M | 988.69M | 926.29M | 1.02B | 999.75M |
| Cash & Short-Term Investments | 318.62M | 142.82M | 701.96M | 548.18M | 747.92M | 596.07M | 666.31M | 529.03M | 463.45M | 336M | 483.28M | 348.27M | 275.61M | 362.79M | 265.58M | 209.36M | 786.14M | 740.92M | 815.92M | 755.31M |
| Cash Only | 309.75M | 133.82M | 419.67M | 61.86M | 176.33M | 115.85M | 154.32M | 187.86M | 164.63M | 118.37M | 274.23M | 221.16M | 96.38M | 234.19M | 147.16M | 90.93M | 117.83M | 118.72M | 491.68M | 446.97M |
| Short-Term Investments | 8.87M | 9M | 282.3M | 486.32M | 571.59M | 480.22M | 511.99M | 341.17M | 298.82M | 217.63M | 209.06M | 127.11M | 179.22M | 128.6M | 118.42M | 118.43M | 668.3M | 622.2M | 324.24M | 308.34M |
| Accounts Receivable | 457.99M | 441.27M | 346.04M | 316.34M | 304.62M | 308.45M | 285.74M | 214.52M | 195.9M | 234.21M | 217.32M | 246.18M | 194.88M | 231.07M | 233.3M | 189.37M | 113.76M | 90.97M | 112.1M | 153.2M |
| Days Sales Outstanding | 107.42 | 80.17 | 86.01 | 86.74 | 104.16 | 91.72 | 79.33 | 80.72 | 99.91 | 90.29 | 98.69 | 90.79 | 118.22 | 117.7 | 93.04 | 90.52 | 78.56 | 91.58 | 105.36 | 80.56 |
| Inventory | 155.47M | 176.47M | 185.8M | 181.5M | 164.87M | 141.86M | 131.41M | 159.31M | 168.54M | 127.6M | 128.92M | 132.41M | 107.52M | 100.12M | 103.28M | 97.61M | 47.76M | 53.91M | 55.98M | 58.55M |
| Days Inventory Outstanding | 137.36 | 163.14 | 231.44 | 245.78 | 208.61 | 298.91 | 270.57 | 260.02 | 292.34 | 225.63 | 219.27 | 218.03 | 265.68 | 222.14 | 195.29 | 194.87 | 287.34 | 234.16 | 283.42 | 231.07 |
| Other Current Assets | 70.96M | 64.64M | 94.95M | 76.65M | 44.62M | 38.95M | 43.52M | 84.93M | 45.69M | 48.61M | 49.48M | 38.88M | 37.01M | 45.02M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 1.67B | 1.7B | 892.48M | 931.23M | 934.5M | 978.14M | 991.05M | 981.66M | 967.94M | 986.85M | 1.01B | 1.04B | 1.08B | 1.1B | 1.21B | 1.24B | 173.56M | 178.14M | 168.12M | 26.11M |
| Property, Plant & Equipment | 82.23M | 82.14M | 71.42M | 71.52M | 72.82M | 75.03M | 74.49M | 75M | 78.07M | 74.94M | 74.67M | 74.56M | 77.96M | 75.57M | 36.67M | 37.09M | 8.51M | 8.79M | 9.59M | 10.13M |
| Fixed Asset Turnover | 4.58x | 5.88x | 4.96x | 4.51x | 3.58x | 3.99x | 3.88x | 3.02x | 2.56x | 3.08x | 2.90x | 2.90x | 2.11x | 3.23x | 5.67x | 6.68x | 13.55x | 11.10x | 11.75x | 13.31x |
| Goodwill | 582.32M | 580.36M | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M | 416.22M | 409.05M | 199.48M | 199.48M | 0 | 0 | 0 | 0 |
| Intangible Assets | 951.96M | 981.47M | 348.54M | 366.31M | 384.07M | 401.83M | 419.59M | 437.35M | 455.12M | 472.88M | 490.64M | 510.98M | 528.82M | 546.65M | 948.9M | 976.1M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 53.17M | 56.15M | 55.7M | 56.37M | 55.61M | 80.6M | 80.15M | 52.48M | 17.32M | 17.82M | 18.11M | 18.41M | 25.74M | 26.8M | 26.28M | 26.78M | 22.54M | 13.91M | 16.05M | 15.98M |
| Total Assets | 2.67B | 2.53B | 2.22B | 2.05B | 2.2B | 2.06B | 2.12B | 1.97B | 1.84B | 1.73B | 1.89B | 1.81B | 1.7B | 1.84B | 1.86B | 1.78B | 1.16B | 1.1B | 1.19B | 1.03B |
| Asset Turnover | 0.14x | 0.19x | 0.17x | 0.15x | 0.12x | 0.14x | 0.14x | 0.12x | 0.11x | 0.13x | 0.12x | 0.13x | 0.09x | 0.10x | 0.11x | 0.10x | 0.10x | 0.09x | 0.10x | 0.14x |
| Asset Growth % | 21.68% | 22.38% | 4.87% | 4.29% | 19.28% | 19.05% | 11.91% | 8.78% | 8.36% | -5.88% | 1.51% | 1.63% | 46.22% | 66.74% | 57.29% | 73.65% | 20.24% | 90.44% | 126.21% | 94.66% |
| Total Current Liabilities | 363.21M | 177.09M | 837.23M | 134.28M | 150.38M | 139.1M | 108.81M | 133.36M | 131.64M | 112.49M | 115.19M | 116.39M | 91.92M | 130.79M | 109.38M | 199.51M | 111.69M | 117.15M | 113.15M | 114.25M |
| Accounts Payable | 14.1M | 20.9M | 15.36M | 18.69M | 20.07M | 10.25M | 12.4M | 15.43M | 13.32M | 11.82M | 19.32M | 10.12M | 8.7M | 17.69M | 18.17M | 12.23M | 1.27M | 1.54M | 3.32M | 4.56M |
| Days Payables Outstanding | 14.48 | 16.33 | 21.46 | 27.51 | 20.62 | 24.77 | 25.9 | 22.81 | 24.82 | 27.38 | 24.7 | 17.1 | 33.76 | 39.16 | 29.55 | 18.09 | 7.93 | 10.36 | 19.51 | 10.08 |
| Short-Term Debt | 208.74M | 0 | 710.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.33M | 13.31M | 99.05M | 89.55M | 89.42M | 89.25M | 89.17M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 667K | 842K | 3.25M | 3.25M | 3.59M | 4.13M | 1.75M | 1.75M | 2.25M | 1.25M |
| Other Current Liabilities | 140.37M | 156.19M | 111.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.25M | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 2.76x | 4.66x | 1.59x | 8.36x | 8.39x | 7.80x | 10.36x | 7.41x | 6.64x | 6.64x | 7.63x | 6.58x | 6.69x | 5.65x | 5.97x | 2.72x | 8.85x | 7.91x | 8.99x | 8.75x |
| Quick Ratio | 2.33x | 3.66x | 1.37x | 7.01x | 7.30x | 6.78x | 9.15x | 6.21x | 5.36x | 5.50x | 6.51x | 5.44x | 5.52x | 4.88x | 5.03x | 2.23x | 8.42x | 7.45x | 8.50x | 8.24x |
| Cash Conversion Cycle | 230.3 | 226.98 | 295.99 | 305.02 | 292.15 | 365.85 | 324 | 317.94 | 367.43 | 288.54 | 293.26 | 291.72 | 350.13 | 300.67 | 258.78 | 267.3 | 357.97 | 315.37 | 369.26 | 301.55 |
| Total Non-Current Liabilities | 2.09B | 2.3B | 880.09M | 1.59B | 1.56B | 1.56B | 1.56B | 1.55B | 1.53B | 1.54B | 1.53B | 1.54B | 1.54B | 1.54B | 1.66B | 1.29B | 790.3M | 790.33M | 790.59M | 791.86M |
| Long-Term Debt | 1.94B | 2.14B | 800.07M | 1.51B | 1.51B | 1.51B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.49B | 1.49B | 1.49B | 1.15B | 788.1M | 787.25M | 786.45M | 785.57M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 47.53M | 42.92M | 8.22M | 0 | 0 | 0 | 11.95M | 13.65M | 0 | 0 | 0 | 0 | 0 | 0 | 28.99M | 3.29M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 106.45M | 113.86M | 71.8M | 77.77M | 56.44M | 54.76M | 40.41M | 30.51M | 31.2M | 37.72M | 28.42M | 44.76M | 45.05M | 45.91M | 135.19M | 135.55M | 171K | 544K | 1.61M | 2.27M |
| Total Liabilities | 2.45B | 2.48B | 1.72B | 1.72B | 1.71B | 1.7B | 1.67B | 1.68B | 1.66B | 1.65B | 1.64B | 1.66B | 1.63B | 1.67B | 1.77B | 1.49B | 901.99M | 907.48M | 903.75M | 906.12M |
| Total Debt | 2.14B | 2.14B | 1.51B | 1.51B | 1.51B | 1.51B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.49B | 1.51B | 1.5B | 1.25B | 877.64M | 876.67M | 875.71M | 874.74M |
| Net Debt | 1.83B | 2.01B | 1.09B | 1.45B | 1.33B | 1.39B | 1.35B | 1.31B | 1.34B | 1.38B | 1.22B | 1.27B | 1.4B | 1.27B | 1.36B | 1.16B | 759.81M | 757.96M | 384.02M | 427.77M |
| Debt / Equity | 9.76x | 43.89x | 3.00x | 4.54x | 3.13x | 4.14x | 3.32x | 5.19x | 8.44x | 17.89x | 6.01x | 9.91x | 22.69x | 8.87x | 15.51x | 4.25x | 3.37x | 4.45x | 3.11x | 7.30x |
| Debt / EBITDA | 9.83x | 7.62x | 6.34x | 6.77x | 9.31x | 7.69x | 8.19x | 10.92x | 12.97x | 12.32x | 13.45x | 13.00x | 20.12x | 18.45x | 13.37x | 26.76x | 11.48x | 15.30x | 11.48x | 9.32x |
| Net Debt / EBITDA | 8.41x | 7.15x | 4.58x | 6.49x | 8.22x | 7.09x | 7.35x | 9.55x | 11.54x | 11.34x | 10.99x | 11.08x | 18.83x | 15.58x | 12.07x | 24.81x | 9.94x | 13.23x | 5.03x | 4.56x |
| Interest Coverage | 33.50x | 51.80x | 50.73x | 46.07x | 31.28x | 40.25x | 37.50x | 25.91x | 21.20x | 20.38x | 23.59x | 21.73x | 12.50x | 16.49x | 10.81x | 10.67x | 43.02x | 27.67x | 43.09x | 53.11x |
| Total Equity | 219.64M | 48.81M | 503.92M | 332.75M | 482.27M | 363.82M | 452.7M | 289.42M | 177.81M | 83.81M | 249.18M | 151.03M | 65.85M | 169.8M | 96.99M | 293.17M | 260.26M | 196.95M | 281.67M | 119.75M |
| Equity Growth % | -54.46% | -86.58% | 11.31% | 14.97% | 171.23% | 334.11% | 81.68% | 91.63% | 170.02% | -50.64% | 156.91% | -48.48% | -74.7% | -13.79% | -65.57% | 144.82% | 285.02% | 30.39% | 184.55% | 13.42% |
| Book Value per Share | 1.79 | 0.41 | 4.12 | 2.68 | 3.81 | 2.81 | 3.48 | 2.24 | 1.38 | 0.64 | 1.86 | 1.13 | 0.48 | 1.23 | 0.70 | 2.06 | 1.84 | 1.37 | 1.92 | 0.81 |
| Total Shareholders' Equity | 219.64M | 48.81M | 503.92M | 332.75M | 482.27M | 363.82M | 452.7M | 289.42M | 177.81M | 83.81M | 249.18M | 151.03M | 65.85M | 169.8M | 96.99M | 293.17M | 260.26M | 196.95M | 281.67M | 119.75M |
| Common Stock | 118K | 118K | 118K | 118K | 123K | 123K | 127K | 127K | 127K | 127K | 132K | 132K | 132K | 135K | 135K | 138K | 138K | 138K | 141K | 142K |
| Retained Earnings | 204.84M | 54.79M | 502.15M | 361.03M | 477.96M | 359.87M | 397.63M | 260.62M | 167.37M | 90.55M | 222.28M | 140.45M | 65.69M | 143.22M | 85.52M | 23.88M | 1.2M | -58.91M | -125.68M | -342.27M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -12.7M | -18.09M | -22.26M | -28.4M | -3.41M | 3.83M | -6.94M | -2.07M | -1.49M | -9.28M | 1.23M | -1.61M | 24K | -922K | -1.84M | -2.02M | -2.79M | -620K | -14K | -24K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |